Andrew D. Leavitt
- Virology top 1%
- HIV Research and Treatment 7
- Internal Medicine top 1%
- Hematology top 1%
- Platelet Disorders and Treatments 20
- Hemophilia Treatment and Research 13
- Blood Coagulation and Thrombosis Mechanisms 7
- Infectious Diseases top 2%
- HIV/AIDS drug development and treatment 7
- Genetics top 5%
- Virus-based gene therapy research 5
-
- Heparin-Induced Thrombocytopenia and Thrombosis 6
-
- Blood properties and coagulation 5
- Co-authors
- Harold VarmusLily ShiueSanford J. ShattilEmmanuelle PasseguéBerthold GöttgensJoshua M. StuartYoon-A KangDamien Reynaud
- Cited by
- VirologyInternal MedicineHematology
- Journals
- Proceedings of the National Academy of Sciences (4 papers)Journal of Biological Chemistry (3 papers)Journal of Clinical Investigation (1 paper)
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Andrew D. Leavitt
69 papers receiving 3.2k citations
Hit Papers
Peers
Comparison fields: 5 of 116
- Virology 690
- Internal Medicine 467
- Hematology 949
- Infectious Diseases 725
- Genetics 244
Countries citing papers authored by Andrew D. Leavitt
This map shows the geographic impact of Andrew D. Leavitt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew D. Leavitt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew D. Leavitt more than expected).
Fields of papers citing papers by Andrew D. Leavitt
This network shows the impact of papers produced by Andrew D. Leavitt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew D. Leavitt. The network helps show where Andrew D. Leavitt may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Andrew D. Leavitt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 3 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 1 | |
| 7 | American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancerbreakdown → | 2021 | 489 |
| 8 | 2021 | 47 | |
| 9 | 2021 | 16 | |
| 10 | 2020 | 0 | |
| 11 | 2019 | 49 | |
| 12 | 2018 | 31 | |
| 13 | 2016 | 28 | |
| 14 | 2016 | 126 | |
| 15 | 2011 | 43 | |
| 16 | 2011 | 17 | |
| 17 | 2009 | 34 | |
| 18 | 2006 | 100 | |
| 19 | 2003 | 11 | |
| 20 | 1996 | 3 |
About Andrew D. Leavitt
Andrew D. Leavitt is a scholar working on Hematology, Virology and Internal Medicine, having authored 71 papers that have together received 3.2k indexed citations. Recurring topics across this work include Platelet Disorders and Treatments (20 papers), Hemophilia Treatment and Research (13 papers), Blood Coagulation and Thrombosis Mechanisms (7 papers), HIV/AIDS drug development and treatment (7 papers), HIV Research and Treatment (7 papers), Heparin-Induced Thrombocytopenia and Thrombosis (6 papers), Blood properties and coagulation (5 papers) and Virus-based gene therapy research (5 papers). The work is most often cited by research in Virology (690 citations), Internal Medicine (467 citations) and Hematology (949 citations). Andrew D. Leavitt has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Harold Varmus, Lily Shiue, Sanford J. Shattil, Emmanuelle Passegué, Berthold Göttgens, Joshua M. Stuart, Yoon-A Kang, Damien Reynaud, Eric M. Pietras and Fernando J. Calero‐Nieto. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.